Cargando…
A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer
The present study was performed to investigate the association of single nucleotide polymorphisms (SNPs) located in the miRNA target sites with the clinical outcomes of first line paclitaxel-cisplatin chemotherapy in advanced NSCLC. Eighty SNPs in miRNA binding sites of cancer related genes selected...
Autores principales: | Hong, Mi Jeong, Lee, Shin Yup, Choi, Jin Eun, Jin, Cheng Cheng, Kang, Hyo Jung, Baek, Sun Ah, Lee, So Yeon, Shin, Kyung Min, Jeong, Ji Yun, Lee, Won Kee, Yoo, Seung Soo, Lee, Jaehee, Cha, Seung Ick, Kim, Chang Ho, Son, Ji Woong, Park, Jae Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941289/ https://www.ncbi.nlm.nih.gov/pubmed/26893365 http://dx.doi.org/10.18632/oncotarget.7433 |
Ejemplares similares
-
PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy
por: Lee, Shin Yup, et al.
Publicado: (2016) -
Genetic Variants in the Wnt Signaling Pathway Are Not Associated with Survival Outcome of Non-Small Cell Lung Cancer in a Korean Population
por: Yoo, Seung Soo, et al.
Publicado: (2016) -
Radiation Recall Dermatitis after Treatment with Paclitaxel and Cisplatin
por: Baek, Seung Woo, et al.
Publicado: (2012) -
The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology
por: Lee, Soyeon, et al.
Publicado: (2016) -
Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer
por: Lee, Shin Yup, et al.
Publicado: (2016)